These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 29298886)

  • 61. Epigenetic regulation of HIV-1 latency in astrocytes.
    Narasipura SD; Kim S; Al-Harthi L
    J Virol; 2014 Mar; 88(5):3031-8. PubMed ID: 24352441
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Resveratrol Reactivates Latent HIV through Increasing Histone Acetylation and Activating Heat Shock Factor 1.
    Zeng X; Pan X; Xu X; Lin J; Que F; Tian Y; Li L; Liu S
    J Agric Food Chem; 2017 Jun; 65(22):4384-4394. PubMed ID: 28471170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ingenol derivates promising for HIV eradication.
    Poveda E
    AIDS Rev; 2014; 16(4):246. PubMed ID: 25373349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.
    Saha B; Parks RJ
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor.
    Lim H; Kim KC; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Virus Res; 2017 Jan; 227():1-5. PubMed ID: 27677464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy.
    Li JH; Ma J; Kang W; Wang CF; Bai F; Zhao K; Yao N; Liu Q; Dang BL; Wang BW; Wei QQ; Kang WZ; Sun YT
    HIV Med; 2020 Dec; 21(11):747-757. PubMed ID: 33369029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo.
    Timmons A; Fray E; Kumar M; Wu F; Dai W; Bullen CK; Kim P; Hetzel C; Yang C; Beg S; Lai J; Pomerantz JL; Yukl SA; Siliciano JD; Siliciano RF
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15763-15771. PubMed ID: 32571938
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
    Colin L; Van Lint C
    Retrovirology; 2009 Dec; 6():111. PubMed ID: 19961595
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency.
    Archin NM; Kirchherr JL; Sung JA; Clutton G; Sholtis K; Xu Y; Allard B; Stuelke E; Kashuba AD; Kuruc JD; Eron J; Gay CL; Goonetilleke N; Margolis DM
    J Clin Invest; 2017 Aug; 127(8):3126-3135. PubMed ID: 28714868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
    Koppel I; Timmusk T
    Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.
    Joshi P; Maidji E; Stoddart CA
    J Biol Chem; 2016 May; 291(19):10332-46. PubMed ID: 26957545
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal.
    Matsuda K; Kobayakawa T; Tsuchiya K; Hattori SI; Nomura W; Gatanaga H; Yoshimura K; Oka S; Endo Y; Tamamura H; Mitsuya H; Maeda K
    J Biol Chem; 2019 Jan; 294(1):116-129. PubMed ID: 30413535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
    Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
    FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Triterpenoids from Ocimum labiatum Activates Latent HIV-1 Expression In Vitro: Potential for Use in Adjuvant Therapy.
    Kapewangolo P; Omolo JJ; Fonteh P; Kandawa-Schulz M; Meyer D
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T cell toxicity of HIV latency reversing agents.
    Zhao M; De Crignis E; Rokx C; Verbon A; van Gelder T; Mahmoudi T; Katsikis PD; Mueller YM
    Pharmacol Res; 2019 Jan; 139():524-534. PubMed ID: 30366100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Interventions in HIV Cure Research.
    Rasmussen TA; Søgaard OS
    Adv Exp Med Biol; 2018; 1075():285-318. PubMed ID: 30030798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
    Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
    Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform.
    Newhard W; Patel M; Cassaday J; Ballard J; Squadroni B; Wu G; Liu J; Yu W; Kozlowski J; Zuck P; Howell B; Hazuda D; Vargo R; Barnard R
    SLAS Discov; 2021 Jun; 26(5):642-654. PubMed ID: 33427012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.